Incidence of Invasive Pneumococcal Disease in Children 3 to 36 Months of Age at a Tertiary Care Pediatric Center 2 Years After Licensure of the Pneumococcal Conjugate Vaccine-Reference-Cited by-同舟云学术

Incidence of Invasive Pneumococcal Disease in Children 3 to 36 Months of Age at a Tertiary Care Pediatric Center 2 Years After Licensure of the Pneumococcal Conjugate Vaccine

Published:2003-04-01 Issue:4 Volume:111 Page:896-899
ISSN:0031-4005
Container-title:Pediatrics
language:en
Short-container-title:

Author:

Lin Philana Ling¹,Michaels Marian G.¹,Janosky Janine¹²,Ortenzo Michelene¹,Wald Ellen R.¹,Mason Edward O.³

Affiliation:

1. Division of Pediatric Infectious Diseases,  Children’s Hospital of Pittsburgh

2. Department of Family Medicine and Clinical Epidemiology,  University of Pittsburgh School of Medicine  Pittsburgh, PA 15213

3. Baylor College of Medicine,  Houston, TX 77030

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Link

https://publications.aap.org/pediatrics/article-pdf/111/4/896/1005257/pe0403000896.pdf

Reference15 articles.

1. Black S, Shinefield H, Firemen B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J.2000;19:187–195

2. American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infection, including the use of the pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics.2000;106:362–366

3. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep.2000;49:1–55

4. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Sixth informational supplement M1150-56. Wayne, PA: National Committee for Clinical Laboratory Standards; 1995

5. Robinson KA, Baughman W, Rothrock G, et al. Active Bacterial Core Surveillance/Emerging Infections Program Network. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: opportunities for prevention in the conjugate vaccine era. JAMA.2001;285:1729–1735

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric invasive pneumococcal disease in Senegal;Médecine et Maladies Infectieuses;2015-11

2. Pautas diagnóstico-terapéuticas en urgencias pediátricas (parte I);FMC - Formación Médica Continuada en Atención Primaria;2013-12

3. Mortality Reductions for Older Adults Differ by Race/Ethnicity and Gender since the Introduction of Adult and Pediatric Pneumococcal Vaccines;Public Health Reports;2011-03

4. Serious Bacterial Infections in Febrile Infants in the Post-Pneumococcal Conjugate Vaccine Era;Academic Emergency Medicine;2009-07

5. Pautas de actuación diagnóstico-terapéuticas en urgencias pediátricas en atención primaria (parte I);FMC - Formación Médica Continuada en Atención Primaria;2009-05